Update: Megola CEO Issues Letter to Shareholders
Anticipating an Exciting 2021 LAS VEGAS, NV / ACCESSWIRE / December 21, 2020 / Megola, Inc. (OTC PINK:MGON) (the "Company"),...
News
ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years
Supports Commercialization of TAEUSⓇ Product for Imaging NAFLD/NASH to December 2023 ANN ARBOR, MI / ACCESSWIRE / December 21, 2020...
Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets...
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
DOYLESTOWN, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain...
Mapi Pharma Provides Enrollment Update in Phase III GA Depot Clinical Trial
Patient recruitment in Phase III trial has surpassed 60% Trial is expanded to Israel with first clinical site at Tel...
HMS to be Acquired by Veritas Capital-Backed Gainwell for $37.00 Per Share
Transaction Expands Gainwell’s Capabilities as an Analytics-Driven Healthcare Technology Provider Cotiviti to Subsequently Acquire Certain Business Lines, Expanding Health Plan...
New Publication in Molecular Cancer Therapeutics Highlights Data from Preclinical Development of exoIL-12™ for the Treatment of Cancer
– exoIL-12 has demonstrated tissue-retained pharmacology, enhanced anti-tumor activity, potent M1 myeloid recruitment, and superior T cell responses in vivo...
PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine
Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine PDS Biotech Announces Mount Sinai Publication...
CannAssist International Xceptol Brand Approved and Included by RangeMe — Increasing SKUs and Providing Access to Over 10,000 Retailers
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC) ("CannAssist International" or the...
PGG Wrightson Seeds to Distribute Marrone Bio Innovations’ Pro Farm UBP Seed Treatment in Uruguay
DAVIS, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Farmers in Uruguay will have a new solution to grow a more...
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”),...
OrthoPediatrics Corp. Announces International Expansion in the United Kingdom
WARSAW, Ind., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Saniona Appoints Chief Legal Officer and Chief Technical Operations Officer to Its Executive Team
PRESS RELEASE December 21, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the...
Nexstim Plc’s Financial Information in 2021
Company announcement, Helsinki, 21 December 2020 at 15.15 (EET) Nexstim Plc’s Financial Information in 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim"...
SELLAS Announces Promising Initial Clinical Data for Galinpepimut-S (GPS) in Combination with Checkpoint Inhibitors in Two Solid Tumor Indications
- Early Data from Study of GPS in Combination with Keytruda® in Patients with Advanced WT1(+) Ovarian Cancer Shows Disease...
Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv
– Comparison of 10 AllocetraTM-treated patients with 37 matched controls showed significant positive responses in state of organ failure, duration...
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D....
The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome
Dravet syndrome is a rare, debilitating and difficult-to-treat lifelong epilepsy that begins in infancyEC approval is based on Phase 3...
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of Research & Development and Chief Medical Officer
Equillium Further Strengthens Management Team with Additional Executive HiresLA JOLLA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq:...
TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline...